Sinha, V. et al. Oral colon-specific drug delivery of protein and peptide drugs. Crit. Rev. Ther. Drug Carrier Syst. 24, 63 tầm 92 (2007).
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J. & Preat, V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Kiểm soát. Giải phóng 116, 1 tầm 27 (2006).
Muheem, A. et al. A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Dược phẩm Ả Rập. J. 24, 413 tầm 428 (2016).
Serra, L., Domenech, J. & Peppas, N. A. Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels. Vật liệu sinh học 27, 5440 tầm 5451 (2006).
Yu, F. et al. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. NS. J. Pharm. 484, 181 tầm 191 (2015).
Mustata, G. & Dinh, S. M. Approaches to oral drug delivery for challenging molecules. Crit. Rev. Ther. Drug Carrier Syst. 23, 111 tầm 135 (2006).
Goldberg, M. & Gomez-Orellana, I. Những thách thức đối với việc cung cấp các đại phân tử bằng miệng. Nat. Thuốc Rev. Đĩa hát. 2, 289 tầm 295 (2003).
Ensign, L. M., Cone, R. & Hanes, J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv. Drug Deliver. Rev. 64, 557 tầm 570 (2012).
Cu, Y. & Saltzman, W. M. Mathematical modeling of molecular diffusion through mucus. Adv. Drug. Deliver. Rev. 61, 101 tầm 114 (2009).
Saltzman, W. M., Radomsky, M. L., Whaley, K. J. & Cone, R. A. Antibody diffusion in human cervical-mucus. Sinh lý. J. 66, 508 tầm 515 (1994).
Chilvers, M. A. & O’Callaghan, C. Local mucociliary defence mechanisms. Nhi khoa. Hô hấp. Mục sư 1, 27 tầm 34 (2000).
Knowles, M. R. & Boucher, R. C. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Lâm sàng. Đầu tư. 109, 571 tầm 577 (2002).
McAuley, J. L. et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J. Lâm sàng. Đầu tư. 117, 2313 tầm 2324 (2007).
Cone, R. Barrier properties of mucus. Adv Drug Deliver. Rev. 61, 75 tầm 85 (2009).
Lai, S. K., Wang, Y. & Hanes, J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliver. Rev. 61, 158 tầm 171 (2009).
Ensign, L. M., Schneider, C., Suk, J. S., Cone, R. & Hanes, J. Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. Tư vấn. Vật chất. 24, 3887 tầm 3894 (2012).
Lai, SK và cộng sự. Vận chuyển nhanh chóng các hạt nano cao phân tử lớn trong chất nhầy tươi chưa pha loãng của con người. Proc. Học viện Natl. Khoa học Hoa Kỳ 104, 1482 tầm 1487 (2007).
Maisel, K., Ensign, L. M., Reddy, M., Cone, R. & Hanes, J. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J. Kiểm soát. Giải phóng 197, 48 tầm 57 (2015).
Cu, Y. & Saltzman, W. M. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. Mol. Pharmaceut. 6, 173 tầm 181 (2009).
Lewis, S. A., Berg, J. R. & Kleine, T. J. Modulation of epithelial permeability by extracellular macromolecules. Vật lý trị liệu. Rev 75, 561 tầm 589 (1995).
McCartney, F., Gleeson, J. P. & Brayden, D. J. Safety concerns over the use of intestinal permeation enhancers: a mini-review. Rào cản mô 4, e117682 (2016).
Maher, S., Mrsny, R. J. & Brayden, D. J. Intestinal permeation enhancers for oral peptide delivery. Adv. Drug Deliver. Rev. 106, 277 tầm 319 (2016).
Whitehead, K., Karr, N. & Mitragotri, S. Safe and effective permeation enhancers for oral drug delivery. Pharmaceut. Res. 25, 1782 tầm 1788 (2008).
Kapitza, C. et al. Oral Insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes. Chăm sóc bệnh tiểu đường 33, 1288 tầm 1290 (2010).
Banerjee, A. et al. Ionic liquids for oral insulin delivery. Proc. Học viện Natl. Khoa học Hoa Kỳ 115, 7296 tầm 7301 (2018).
Iyer, H., Khedkar, A. & Verma, M. Oral insulin – a review of current status. Các nghĩa vụ về bệnh tiểu đường. Metab. 12, 179 tầm 185 (2010).
Lerner, A. & Matthias, T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. tự miễn dịch. Mục sư 14, 479 tầm 489 (2015).
Pridgen, E. M. et al. Transepithelial transport of Fc-targeted nanoparticles by the neonatal Fc receptor for oral delivery. Khoa học. Dịch. Med. 5, 213ra167 (2013).
Kim, K. S., Suzuki, K., Cho, H., Youn, Y. S. & Bae, Y. H. Oral nanoparticles exhibit specific high-efficiency intestinal uptake and lymphatic transport. Nano ACS. 12, 8893 tầm 8900 (2018).
Kim, K. S., Kwag, D. S., Hwang, H. S., Lee, E. S. & Bae, Y. H. Immense Insulin intestinal uptake and lymphatic transport using bile acid conjugated partially uncapped liposome. Mol. Pharmaceut. 15, 4756 tầm 4763 (2018).
Cao, Z., Zhang, L. & Jiang, S. Superhydrophilic zwitterionic polymers stabilize liposomes. Langmuir 28, 11625 tầm 11632 (2012).
Lu, Y. et al. Micelles with ultralow critical micelle concentration as carriers for drug delivery. Nat. Sinh học. Anh 2, 318 tầm 325 (2018).
Thwaites, D. T. & Anderson, C. M. H. The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. Brit. J. Pharmacol. 164, 1802 tầm 1816 (2011).
Salim, S. Y. & Soderholm, J. D. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Viêm. Ruột Dis. 17, 362 tầm 381 (2011).
Soderholm, J. D. et al. Reversible increase in tight junction permeability to macromolecules in rat ileal mucosa in vitro by sodium caprate, a constituent of milk fat. Digest. Dis. Sci. 43, 1547 tầm 1552 (1998).
Brake, R., Vogl, A.W. & Mitchell, A.W.M. Grey's Anatomy cho sinh viên (Elsevier/Churchill Livingstone, 2005).
Frolund, S., Holm, R., Brodin, B. & Nielsen, C. U. The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics. Br. J. Pharmacol. 161, 589 tầm 600 (2010).
Willems, D., Cadranel, S. & Jacobs, W. Measurement of urinary sugars by HPLC in the estimation of intestinal permeability-evaluation in pediatric clinical-practice. lâm sàng. hóa học. 39, 888 tầm 890 (1993).
Jiang, X. H., Li, N. & Li, J. S. Intestinal permeability in patients after surgical trauma and effect of enteral nutrition versus parenteral nutrition. World J. Gastroentero. 9, 1878 tầm 1880 (2003).
Anderson, C. M. H. et al. H+/amino acid transporter 1 (PAT1) is the imino acid carrier: an intestinal nutrient/drug transporter in human and rat. Tiêu hóa 127, 1410 tầm 1422 (2004).
Broberg, M. L. et al. Function and expression of the proton-coupled amino acid transporter PAT1 along the rat gastrointestinal tract: implications for intestinal absorption of gaboxadol. Brit. J. Pharmacol. 167, 654 tầm 665 (2012).
Olmsted, S. S. et al. Diffusion of macromolecules and virus-like particles in human cervical mucus. Sinh lý. J. 81, 1930 tầm 1937 (2001).
